e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Pathophysiology of respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of bone marrow mononuclear cell therapy in an experimental model of acute lung injury
M. Morales, L. F. Prota, R. Lassance, T. Maron-Gutierrez, R. Castiglione, C. Baez-Garcia, S. Abreu, P. Rocco (Rio de Janeiro, Brazil)
Source:
Annual Congress 2008 - Pathophysiology of respiratory diseases
Session:
Pathophysiology of respiratory diseases
Session type:
E-Communication Session
Number:
3093
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Morales, L. F. Prota, R. Lassance, T. Maron-Gutierrez, R. Castiglione, C. Baez-Garcia, S. Abreu, P. Rocco (Rio de Janeiro, Brazil). Effects of bone marrow mononuclear cell therapy in an experimental model of acute lung injury. Eur Respir J 2008; 32: Suppl. 52, 3093
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effects of bone marrow mononuclear cell therapy in an experimental model of silicosis
Source: Annual Congress 2008 - Respiratory pathophysiology from cell and animal research
Year: 2008
Bone marrow-derived mononuclear cell therapy reduces lung and distal organ damage in severe sepsis
Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury
Year: 2010
The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2008 - Pathophysiology of acute lung injury
Year: 2008
A study on markers of pulmonary endothelial cells in acute lung injury induced by bone marrow extract injection inrabbits
Source: Eur Respir J 2004; 24: Suppl. 48, 720s
Year: 2004
Impact of bone marrow mononuclear cell administration route on lung and distal organs in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment
Year: 2011
Beneficial effects of autologous bone marrow mononuclear cell transplantation via the trachea against elastase-induced emphysema in rabbits
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009
Monitoring of lung function and airways inflammation after bone marrow transplantation
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Alterations of bone marrow derived endothelial progenitor cells following acute pulmonary embolism in mice
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Injection of bone marrow cells reduces bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2005 -
In vivo
- approaches to lung injury
Year: 2005
Intratracheal
versus
intravenous bone marrow mononuclear cell therapy in pulmonary and extrapulmonary acute lung injury: Which is the best administration route?
Source: Annual Congress 2010 - Acute lung injury and ventilator-induced lung injury
Year: 2010
Monitoring of lung function and bronchial inflammation after bone marrow transplantation: preferential recruitment of lymphocytes into the airways
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006
In vivo
chracterization of bone marrow derived progenitor cells in airway remodeling in murine asthma model
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
The contribution of bone marrow derived progenitor cells to lung remodelling
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008
Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis
Source: Eur Respir J 2011; 37: 1217-1225
Year: 2011
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
Effect of intratracheal transplantation of bone marrow-derived endothelial progenitor cell on cigarette smoking-induced emphysema in mice
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Late-breaking abstract: Comparison of bone marrow derived-mononuclear cells with mesenchymal stem cells on inflammatory and remodeling processes in experimental chronic allergic asthma
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept